TrialPath

1 study

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Lupus (SLE)

    📍 Hospital for Special Surgery · New York, NY · Get directions →

    ONT01 is a drug that is being studied for the treatment of Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) and is not approved by the FDA. The purpose of this study is to better determine whether ONT01 is safe and tolerated by people with lupus nephritis or SLE.

    ✓ Study care freeEarly Phase 1Ages 18+Learn more →